NCT03304080 2025-07-18
Anastrozole, Palbociclib, Trastuzumab and Pertuzumab in HR-positive, HER2-positive Metastatic Breast
Icahn School of Medicine at Mount Sinai
Phase 1/2 Active not recruiting
Icahn School of Medicine at Mount Sinai
Alliance for Clinical Trials in Oncology
National Taipei University of Nursing and Health Sciences
Odense University Hospital